Admit date: 1-WM 2-WM 3.2-WM 3.7-WM 4-WM DSM-V diagnoses: Please list all diagnoses (psychiatric, chemical dependency and medical)
|
|
- Rudolph Cook
- 5 years ago
- Views:
Transcription
1 Substance Use Disorder Withdrawal Management Prior Authorization and Continued Care Request (Use for American Society of Addiction Medicine [ASAM] withdrawal management levels of care) To avoid delays in processing, please fill this form out completely and fax to Amerigroup Washington, Inc. at If you have any questions, please contact Provider Services at Member information Name: Amerigroup ID: Date of birth: Address: City: State: ZIP code: Provider information Facility name: Facility NPI/TIN: Facility address: Office contact: Phone: Fax: Provider name: Provider NPI: ASAM level of care: Admit date: 1-WM 2-WM 3.2-WM 3.7-WM 4-WM DSM-V diagnoses: Please list all diagnoses (psychiatric, chemical dependency and medical) Current risk factors Suicide None Ideation Intent without means Intent with means Contracted not to harm self Homicide None Ideation Intent without means Intent with means Contracted not to harm others Physical or sexual abuse or child/elder neglect: If yes, patient is: Victim Perpetrator Both Neither, but abuse exists in family WAPEC September 2018
2 Current risk factors Explain any significant history of suicidal, homicidal, impulse control or other behavior that may impact the patient s level of functioning: Job/school Housing Legal issues Family history of mental illness or substance abuse Abuse has been legally reported: Abuse or neglect involving a child or elder: Risk history Page 2 of 6
3 Vital signs Date Time BP Respiration Pulse Temp ASAM dimensions I: Intoxication/withdrawal potential Alcohol withdrawal CIWA score: BAL Breathalyzer results Withdrawing from other substances? If yes, provide all currently used substances: History of blackouts? History of seizures? History of DTs? Current withdrawal symptoms Tremor (shakes) Agitation Sweating Tachycardia Craving for alcohol Irritability Disorientation Hypertension Anxiety Loss of appetite Visual hallucinations Fever Insomnia Vomiting Auditory hallucinations Seizure Vivid dreams Headache Tactile hallucinations Opioid withdrawal (select the category which best describes the current symptoms) COWS score: Occasional yawning, slight pupillary dilation, rhinorrhea, chills, mild anxiety Frequent yawning, piloerection, abdominal cramps, nausea, loose stools, body aches, mild elevation of BP or pulse, mod sweating, anxiety, tremulousness, restlessness, irritability Vomiting, diarrhea, observable tremor, mild fever, mod elevation in BP or pulse, significant anxiety, sweating, restlessness, body aches, pupillary dilation, piloerection Debilitating vomiting and diarrhea, agitation, gross tremor, fever, severe elevation of BP or pulse II. Significant active co-occurring physical health conditions? II. Significant active co-occurring behavioral health conditions? Page 3 of 6
4 ASAM dimensions III. Comprehension III. Ability to understand and follow treatment recommendations? Awake Alert Knows name Knows location Knows date Good Fair Poor IV. Level of cooperation? IV. Commitment to WD management process? V. Imminent risk of relapse? Cooperative Sometimes cooperative Uncooperative Committed Questionable Low commitment VI. Support from family/friends/community? Strong support Moderate support Poor support Medications (optional for nonphysicians): Current medications Dosage Frequency Patient s treatment history, including all levels of care: Mental Date of last health level episode/session of care Number of distinct episodes/ sessions Substance Use Disorder (SUD) level of care Number of distinct episodes /sessions Date of last episode/ session Inpatient mental health Inpatient/RTC SUD Page 4 of 6
5 Patient s treatment history, including all levels of care: PHP mental health PHP SUD IOP mental health IOP SUD Outpatient mental health Outpatient SUD Withdrawal management/detox Treatment goals Objective outcome criteria by which goal achievement is measured Discharge plan (SUD, BH, PCP appointments, housing, community supports) Expected outcome and prognosis Return to normal functioning Expect improvement, anticipate less than normal functioning Relieve acute symptoms, return to baseline functioning Maintain current status, prevent deterioration Page 5 of 6
6 Number of days: Provider signature: Phone: Estimated discharge date: Date: Fax: Disclaimer: Authorization indicates that Amerigroup determined medical necessity has been met for the requested service(s) but does not guarantee payment. Payment is contingent upon the eligibility and benefit limitations at the time services are rendered. Page 6 of 6
Mental Health Outpatient Treatment Report Form
Mental Health Outpatient Treatment Report Form INSTRUCTIONS 1. Complete all sections entirely 2. Fax the form to 888-240-4609 / Georgia Families 360º members 888-375-5070 3. You will receive a confirmation
More informationElectroconvulsive Therapy Prior Authorization Request
Electroconvulsive Therapy Prior Authorization Request Medicare Advantage To request electroconvulsive therapy (ECT) services, please submit this form electronically at https://www.availity.com or via fax
More informationBehavioral Health Service Request Form Detox and Substance Abuse Rehab
Medicaid Call for Pre-Certification of Admissions: 1-855-620-1861 Kentucky Medicaid Fax: 1-877-338-3686 Standard Request Requests for prior authorization (with supporting clinical information and documentation)
More informationBehavioral Health Service Request Form Detox and Substance Abuse Rehab
Arkansas 855-538-0454 Connecticut 855-538-0454 Florida 855-538-0454 Georgia 800-424-5412 Illinois 800-504-2766 Kentucky 855-620-1861 Louisiana 855-538-0454 Arkansas 855-710-0159 Connecticut 888-365-3233
More informationBehavioral Health Service Request Form Detox and Substance Abuse Rehab
Please Submit to the Dedicated Fax Line Below Medicaid Call for Pre-Certification of Admissions: 888-453-2534 New Jersey Medicaid Fax: 855-703-8082 Lev el of Care: Place of Serv ice: Detox Substance Abuse
More informationBehavioral Health Service Request Form Detox and Substance Abuse Rehab
Please Submit to the Dedicated Fax Line Below Medicaid Call for Pre-Certification of Admissions: 888-588-9842 South Carolina Medicaid Fax: 888-339-8293 Lev el of Care: Place of Serv ice: Detox Substance
More informationWithdrawal.
Withdrawal Shamim Nejad, MD Director, Adult Burns & Trauma Psychiatry Division of Psychiatry and Medicine Medical Director, Addiction Consultation Team MGH Center for Addiction Medicine Massachusetts General
More informationMedical Necessity Criteria 2017
Medical Necessity Criteria 2017 The New Directions Medical Necessity Criteria have been revised. The new version will be effective January 1, 2017. See https://www.ndbh.com/providers/behavioralhealthplanproviders.aspx.
More informationMEMBER INFORMATION First Name, Middle Initial
CHOOSE ONE OF THE FOLLOWING: Inpatient Hospital (21) Inpatient Psychiatric Facility (51) Psychiatric Facility Partial Hospitalization (52) Please contact WellCare for prior authorization of Inpatient services
More informationBehavioral Health Prior Authorization Form
Behavioral Health Prior Authorization Form Iowa Behavioral Health (BH) Utilization Management (UM) at 1-844-214-2469. Today s date: Date of admission/service start: Please note: Authorization is based
More informationMEMBER INFORMATION First Name, Middle Initial
Behavioral Health Service Requests (Arizona, Connecticut and Kentucky only) Inpatient and Partial Hospitalization Services Intensive Outpatient and Routine Outpatient Services Psychological and Neuropsychological
More informationService Request Form. Intensive Outpatient Program (IOP): Continuing Review Request
Please fax your completed form and treatment plan to Optum Idaho at 1-855-708-9282. Service Request Form Intensive Outpatient Program (IOP): Continuing Review Request Section 1: Date 1. Date of Submission
More informationSUD Requirements. Proprietary
SUD Requirements Triage screening to determine eligibility and appropriateness (proper member placement) for admission and referral. A comprehensive bio-psychosocial evaluation must be completed prior
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationDrug & Alcohol Detox:
Drug & Alcohol Detox: Beginning Stages of Addiction Treatment If you ve tried to detox on your own and failed, you are not alone. The good news is that research shows those who commit to a rehabilitation
More information*IN10 BIOPSYCHOSOCIAL ASSESSMENT*
BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding
More informationSubstance Use Disorders. A Major Problem. Defining Addiction 2/24/2009. Lifetime rates of alcoholism estimated at 13.4 %
Substance Use Disorders A Major Problem Lifetime rates of alcoholism estimated at 13.4 % Rates of drug abuse estimated at 6% Marijuana is most frequent Approximately 600,000 deaths each year from substance
More informationClinical Assessment. Client Name (Last, First, MI) ID # Medicaid # DOB: Age:
Clinical Assessment Client Name (Last, First, MI) ID # Medicaid # DOB: Age: Sex: Ethnic Group: Marital Status: Occupation: Education: Multiaxial Diagnosis Axis I: Clinical Disorders / Other Conditions
More informationStabilization Algorithm
VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders Stabilization Algorithm Stabilization Pocket Card 1 Patient and Time Information Clinical Institute Withdrawal Assessment
More informationOpioid dependence: Detoxification
Opioid dependence: Detoxification What is detoxification? A. Process of removal of toxins from the body? B. Admitting a drug dependent person in a hospital and giving him nutrition? C. Stopping drug use
More informationAddiction and Recovery Treatment Services (ARTS) Service Authorization Review Form Initial Requests ASAM Levels 2.1/2.5/3.1/3.3/3.5/3.7/4.
Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form Initial Requests ASAM Levels 2.1/2.5/3.1/3.3/3.5/3.7/4.0 No Service Authorization Needed for ASAM Levels 0.5/1.0/OTP/OBOT
More informationInitial Substance Use Assessment
Date of Assessment: Source of Referral: Choose an item. Persons Present: Client and Provider only Transportation Assistance Needed: Yes No Member has a Primary Care Physician (PCP)? Yes No If yes PCP,
More informationPSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH
PSYCHIATRIC CO-MORBIDITY STEVE SUGDEN MD MPH OVERVIEW: PSYCHIATRIC DISORDERS Mood Disorders Anxiety Disorders Psychotic Disorders Personality Disorders PTSD Eating Disorders EXAMPLE What is the diagnosis?
More informationAddiction and Recovery Treatment Services (ARTS) Service Authorization Review Form ASAM Levels 2.1/2.5/3.1/3.5/3.7/4.0
Member Name: Member ID: Provider Group/Clinic: Street Address: City State Zip: Phone: Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form ASAM Levels 2.1/2.5/3.1/3.5/3.7/4.0
More informationAhsan U. Rashid, M.D., F.A.C.P.
Ahsan U. Rashid, M.D., F.A.C.P. OPIOID MAINTENANCE AND CONSENT Instructions: Review this document before signing. This document will help both the patient and caregivers in establishing a medical program
More informationMedications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives
More informationSAMPLE INITIAL EVALUATION TEMPLATE
I. Demographic Information Date: SAMPLE INITIAL EVALUATION TEMPLATE Name: Address: Phone (Home/Cell): Phone (Work): Date of Birth: Guardianship (for children and adults when applicable): Marital Status:
More informationTriage/Low Demand Shelter Screening Form
Triage/Low Demand Shelter Screening Form Arrest History Date: Charge Type: Charge: Arrest Date: Was client Convicted? Conviction Date: City: State: County: SPN/Jacket # (Can be found on the www.sheriffleefl.org)
More informationChapter 7. Screening and Assessment
Chapter 7 Screening and Assessment Screening And Assessment Starting the dialogue and begin relationship Each are sizing each other up Information gathering Listening to their story Asking the questions
More informationPART VI: TAPERING OPIOIDS ROBERT JENKINSON MD MARCH 7, 2018
PART VI: TAPERING OPIOIDS ROBERT JENKINSON MD MARCH 7, 2018 TAPERING OPIOIDS GETTING STARTED ON OPIOIDS IS EASY BUT GETTING PATIENTS OFF IS HARD WE ARE ARE OBLIGED TO TAPER PATIENTS DOWN AND OFF OPIOIDS
More informationAdult Mental Health Rehabilitation Treatment Request Form
Adult Mental Health Rehabilitation Treatment Request Form Please print clearly. Incomplete or illegible forms will delay processing. Please return the completed form to AmeriHealth Caritas Louisiana s
More informationBehavioral Health Psychiatric Residential Treatment Facility Referral Form
Behavioral Health Psychiatric Residential Treatment Facility Referral Form www.amerihealthcaritasla.com Psychiatric residential treatment facility (PRTF) referral information Date of referral: Referral
More informationSCID-I Version 2.0 (for DSM-IV) Non-Alcohol Use Disorders
SCID-I Version 2.0 (for DSM-IV) Non-Alcohol Use Disorders *NON-ALCOHOL SUBSTANCE USE DISORDERS* (LIFETIME DEPENDENCE AND ABUSE) Now I am going to ask you about your use of drugs or medicines. SHOW DRUG
More informationInitial Evaluation Template
Demographic Information (Please complete all questions on this form) Member Name: Date: Name: Address: Phone (Home): Phone (Work): Date of Birth: Social Security #: Guardianship (for children and adults
More informationAddiction and Recovery Treatment Services (ARTS) Service Authorization Review Form Initial Requests ASAM Levels 2.1/2.5/3.1/3.3/3.5/3.7/4.
Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form Initial Requests ASAM Levels 2.1/2.5/3.1/3.3/3.5/3.7/4.0 No Service Authorization Needed for ASAM Levels 0.5/1.0/OTP/OBOT
More informationAddiction and Recovery Treatment Services (ARTS) Service Authorization Review Form ASAM Levels 2.1/2.5/3.1/3.5/3.7/4.0
Member Name: Member ID: Provider Group/Clinic: Street Address: City State Zip: Phone: Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form ASAM Levels 2.1/2.5/3.1/3.5/3.7/4.0
More informationPsychiatric Residential Treatment Facility Referral
Psychiatric Residential Treatment Facility Referral Psychiatric residential treatment facility (PRTF) referral information Date of referral: Referral contact: Phone number: Referring facility or agency:
More informationPhysical Issues: Emotional Issues: Legal Issues:
Men s Facility 1119 Ferry Street Lafayette, IN 47901 Phone: (765) 807-0009 Fax: (765) 807-0030 Hope Apartments 920 N 11th St. Lafayette, IN 47904 Phone: (765) 742-3246 Fax: (765) 269-9110 APPLICATION FOR
More informationControlled Substance and Wellness Agreement
Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)
More informationINITIAL MENTAL HEALTH ASSESSMENT
1. Identifying Information (age, gender, ethnicity, preferred language, relationship status, sexual orientation, gender identity, living arrangement): 2. Presenting Mental Health Problem (referral source,
More informationAddiction and Recovery Treatment Services (ARTS) Service Authorization Review Form Extension Requests ASAM Levels 2.1/2.5/3.1/3.3/3.5/3.7/4.
Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form Extension Requests ASAM Levels 2.1/2.5/3.1/3.3/3.5/3.7/4.0 No Service Authorization Needed for ASAM Level 0.5/1.0/OTP/OBOT
More informationMEDICATION MANAGEMENT AGREEMENT
MEDICATION MANAGEMENT AGREEMENT The goal of this agreement is to ensure that you and your physician comply with all state and federal regulations concerning the prescribing of controlled substances. The
More informationClinical Policy: Lofexidine (Lucemyra) Reference Number: ERX.NPA.88 Effective Date:
Clinical Policy: (Lucemyra) Reference Number: ERX.NPA.88 Effective Date: 07.31.18 Last Review Date: 08.18 Revision Log See Important Reminder at the end of this policy for important regulatory and legal
More informationService Review Criteria
Pre-Review Review for HUM 26: immediate health/safety concerns. If MET, refer to medical staff and outreach phone call to Provider. Please note concerns here and in the Clinical Justification: Review for
More informationELEMENTAL CENTER MENTAL HEALTH INTAKE FORM
1 Please complete all information on this form. It may seem long, but most of the questions require only a check, so it will go quickly. Thank You! Personal Information First Name Last Name Gender DOB
More informationIdentifying Data. Provider Information. Diagnoses
Outpatient Treatment Request OutpatientTreatmentRequest Faxcompletedformto:8669494846 Filloutcompletelytoavoiddelays Date: / / RequestType(Checkone): Standard Expedited(additionalinformationrequiredbelow)
More informationAdult 65D-30 Intervention ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA
Adult 65D-30 Intervention ASAM Level.05 ADMISSION CRITERIA Place a check in the yes or no box that indicates validation or lack ASAM Requirements Withdrawal and of validation for placement into this level
More informationSubstance and Alcohol Related Disorders. Substance use Disorder Alcoholism Gambling Disorder
Substance and Alcohol Related Disorders Substance use Disorder Alcoholism Gambling Disorder What is a Substance Use Disorder? According to the DSM-5, a substance use disorder describes a problematic pattern
More informationMENTAL HEALTH AND MENTAL ILLNESS: OUR JOURNEY ACROSS THE CONTINUUM LLI PROGRAM OCTOBER 5, 2018 VIRGINIA F. RIGGS MS, MSN, RN
MENTAL HEALTH AND MENTAL ILLNESS: OUR JOURNEY ACROSS THE CONTINUUM LLI PROGRAM OCTOBER 5, 2018 VIRGINIA F. RIGGS MS, MSN, RN OBJECTIVES: Focus on a continuum from mental health to mental illness Examine
More informationPROVIDER ALERT. Alert #: PA Issued: April Detoxification Providers. Revisions to Detoxification Protocols.
PROVIDER ALERT Alert #: PA 2011-11 Issued: April 2011 To: Subject: Detoxification Providers Revisions to Detoxification Protocols Dear Provider, The CT Behavioral Health Partnership is dedicated to ongoing
More informationSubstance Abuse Level of Care Criteria
Substance Abuse Level of Care Criteria Table of Contents SUBSTANCE ABUSE OUTPATIENT: Adolescent... 3 SUBSTANCE ABUSE PREVENTION: Adult... 7 OPIOID MAINTENANCE THERAPY: Adult... 8 SUBSTANCE ABUSE INTERVENTION:
More informationNEW PATIENT REGISTRATION PLEASE COMPLETE ALL ITEMS ON EACH PAGE. Name (Last, First, M.I.) Address. City State Zip Code. Phone ( ) Work ( ) Cell ( )
NEW PATIENT REGISTRATION PLEASE COMPLETE ALL ITEMS ON EACH PAGE Date Name (Last, First, M.I.) Address City State Zip Code Phone ( ) Work ( ) Cell ( ) Date of Birth Age Marital Status SSN Employer Employer
More informationA new model for prescribing varenicline
Pharmacist Independent Prescribers in partnership with A new model for prescribing varenicline Dear Stop Smoking Advisor You will be aware of the stop smoking drug varenicline that goes under the brand
More informationAPPENDIX 7 CLINICAL INSTITUTE NARCOTIC ASSESSMENT (CINA) SCALE FOR WITHDRAWAL SYMPTOMS
APPENDIX 7 CLINICAL INSTITUTE NARCOTIC ASSESSMENT (CINA) SCALE FOR WITHDRAWAL SYMPTOMS The Clinical Institute Narcotic Assessment (CINA) Scale measures 11 signs and symptoms commonly seen in patients during
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service
1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 0 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 1 1: Acute Intoxication and/or Withdrawal Potential Risk Rating: 2 The patient
More informationModule II Opioids 101 Opiate Opioid
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module II Opioids 101 Module II Goals of the Module This module reviews the following:! Opioid addiction and the brain!
More informationACUTE INPATIENT TREATMENT
I. Definition of Service: ACUTE INPATIENT TREATMENT Acute inpatient hospitalization represents the most intensive level of psychiatric care. Multidisciplinary assessments and multimodal interventions are
More informationChild and Adolescent Residential Services Referral Packet
Patient Name: Date of Birth: Child and Adolescent Residential Services Referral Packet Please do not reply. See attached questions. We require that you directly answer all questions in this referral packet.
More informationMINDFUL WELLNESS CENTER, PLLC
PATIENT HISTORY NAME DATE PLEASE TAKE YOUR TIME AND COMPLETE THE ENTIRE FORM. You may use the back if needed for more explanation. Identifying Information: Date of Birth: Age: Sex: Place of Birth: Religion:
More informationClinical UM Guideline. This document provides medical necessity criteria for levels of care relating to substance and addictive disorders.
Clinical UM Guideline Subject: Substance-Related and Addictive Disorder Treatment Guideline #: CG-BEH-04 Current Effective Date: 04/05/2016 Status: Revised Last Review Date: 02/04/2016 Description This
More informationAmbulatory Intoxication and Withdrawal Management: A Clinical Monograph
Ambulatory Intoxication and Withdrawal Management: A Clinical Monograph Revised December 2016 1 Table of Contents I. Ambulatory Intoxication and Withdrawal Management... 3 II. Evaluation and Assessment
More informationVanessa Schulte, CCMA Practice Administrator Huntsville Hospital Pediatric Neurology
Kimberly L. Limbo, MD Kellie D. Anderson, CRNP Dear Parent, Thank you for choosing Huntsville Hospital Pediatric Neurology for your child s medical care. Our website should help answer any questions about
More informationASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA
Print Client Name: Client Identification Number: Date: Adolescent 65D-30 Intervention ASAM Level.05 ADMISSION CRITERIA Acute Intoxication and /or Withdrawal Biomedical Conditions and of validation for
More informationWithdrawal Why is stopping substance use so difficult?
Withdrawal Why is stopping substance use so difficult? Withdrawal occurs in drug dependant individuals who stop or considerably reduce their drug use. Definitions Dependence syndrome is characterized by
More informationOverview of Psychoactive Drug use
Overview of Psychoactive Drug use By Dr. Oladosu Ahmed Kayode Specialist in mental health Attending physician Dept. of psychiatry, GH Ilorin & Hopeville Psychiatric Hospital, Ilorin. Learning objectives
More informationADULT Addictions Treatment: Medically Monitored Residential Treatment (3B)
ADULT Addictions Treatment: Medically Monitored Residential Treatment (3B) Program Medically Monitored Short Term Residential treatment provides 24 hour professionally directed evaluation, care, and treatment
More informationClinical UM Guideline
Clinical UM Guideline Subject: Substance-Related and Addictive Disorder Treatment Guideline #: CG-BEH-04 Publish Date: 03/29/2018 Status: Reviewed Last Review Date: 02/27/2018 Description This document
More informationPatient Name Date of Birth Page 1 of 6
2545 W. Hillcrest Dr. #205 Thousand Oaks, CA 91320 Admissions: 888.822.8938 Fax: 805.273.5246 Dear Medical Professional, This patient is seeking care to address eating disorder behaviors. For the patient
More informationCMBHS Clinical Management of Behavioral Health Services
Client: CMBHS Clinical Management of Behavioral Health Services Detoxification Assessment Assessment Information (te: All are Required fields) Assessment Number Assessment Date Assessment Type Contact
More informationNew Service Provider Provider Type Provider Name Phone Ext
Substance Abuse Adult Assessment AST022 Assessment Information Assessment Number Assessment Date Assessment Type Contact Type Assessment Site Referred by Client Issue Presenting Problem Expectations Service
More informationROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS
ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS Dr. Anita Rao? ASK SCREEN Refer HELP T T Ranganathan Clinical Research Foundation TTK Hospital IV Main Road, Indira
More informationName: Gender: male female Age: Date of birth: / / Preferred phone: cell home work other. Alternate phone: cell home work other.
Casey Alexander Paleos, MD NEW CLIENT INTAKE FORM 775 Park Avenue, Suite 200-2 Huntington, NY 11743 tel 631-629-5887 Date: / / BASIC INFORMATION Name: Gender: male female Age: Date of birth: / / Preferred
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Lucemyra) Reference Number: CP.PMN.152 Effective Date: 07.31.18 Last Review Date: 08.18 Line of Business: Commercial, HIM, Medicaid Revision Log See Important Reminder at the end of this
More informationCorinna Mosher, M.D. A Medical Corporation 415 E. Rolling Oaks Drive Suite #280 Thousand Oaks, CA (805) Fax (805)
Patient Registration: Corinna Mosher, M.D. A Medical Corporation 415 E. Rolling Oaks Drive Suite #280 Thousand Oaks, CA 91361 (805) 496-8522 Fax (805) 496-0469 Last Name: First Name: MI: Address: City:
More informationROSC & MAT II: Opioid Treatment Services
ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify
More informationDISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS LECTURE COVERS. SUDs ARE IMPORTANT. I have nothing to declare
MANAGEMENT OF OPIOID USE DISORDERS DISCLOSURES Marc A Schuckit Distinguished Professor of Psychiatry, UCSD Medical School I have nothing to declare SUDs ARE IMPORTANT Affect > 20% of your patients Are
More informationINFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine
INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine The purpose of this agreement is to give you information about the medications you will be taking for
More informationEliada Assessment Center Application for Services
Student s Name: Record # Date of Birth: Race: Biological Sex: Male Female Gender Identity: Male Female Transgender/Non-Binary Date Placement Needed: SSN: - - Legal Custodian: Name, Address, Phone, Email
More informationAACN PCCN Review. Behavioral
AACN PCCN Review Behavioral Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com 0 Behavioral I. INTRODUCTION PCCN
More informationNORTHLAKE YOUTH ACADEMY Psychiatric Residential Treatment Facility Hwy. 190 Mandeville, Louisiana Phone: Fax:
NORTHLAKE YOUTH ACADEMY Psychiatric Residential Treatment Facility 23515 Hwy. 190 Mandeville, Louisiana 70470 Phone: 985-626-6534 Fax: 985-626-6398 Completed by: Date: Resident s Name: Resident s Date
More informationPreferred Name (s): Local Address: City: State: Zip: Permanent Address: City: State: Zip: Years of Education: Occupation: Gender: M F
Today Date: Client Name(s) : Psychological Consultants Northgate Center 1210 ½ -7 th Street NW, Suite 216 Rochester, MN 55901 www.psychologicalconsultants1.com Office: (507) 252-9292 Fax: (507) 252-9203
More informationASAM CRITERIA 3 rd Edition
ASAM CRITERIA 3 rd Edition Presented by Mark Disselkoen, LCSW, LADC CASAT Based on DSM 5 & The ASAM Criteria Manual The ATTC Network Ten Regional Centers Central Rockies ATTC is now the Mountain Plains
More informationMEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution
MEDICATION GUIDE Morphine Sulfate (MOR feen SUL fate) (CII) Oral Solution IMPORTANT: Keep morphine sulfate oral solution in a safe place away from children. Accidental use by a child is a medical emergency
More informationBroward Oncology Associates, P.A. PATIENT INFORMATION
NAME: BIRTHDATE: AGE: LOCAL ADDRESS (Street city state zip): HOME TELEPHONE# CELL # SOCIAL SECURITY #: - - SEX MARITAL STATUS WHAT IS YOUR HT? WHAT IS YOUR WT? EMPLOYER WORK# SPOUSE'S NAME SPOUSE'S EMPLOYER
More informationUnderstanding Mental Illness A Review of the Disorders
Understanding Mental Illness A Review of the Disorders Objectives Define and describe mental illness To be able to recognize signs, symptoms, and behaviors of the major categories of mental illness Recognition
More informationMEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP
MEDICATION GUIDE Oxycodone Hydrochloride (ox-ee-co-dohn) (CII) Oral Solution, USP IMPORTANT: Keep oxycodone hydrochloride oral solution in a safe place away from children. Accidental use by a child is
More informationOpioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine
Natural derivatives of opium poppy - Opium - Morphine - Codeine Opioid Agonists Semi synthetics: Derived from chemicals in opium -Diacetylmorphine Heroin - Hydromorphone Synthetics - Oxycodone Propoxyphene
More informationOpioids Research to Practice
Opioids Research to Practice May 2013 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Case 32 yo female brought in after heroin overdose
More information~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Patient General Information
Patient General Information Name: (first) (middle) (last) Date of Birth: / / (mo) (day) (year) 中 文名字 : Gender: Occupation: Address: (street, apt) Phone #: (city, state, zip code) Email: Emergency Contact:
More informationAmarillo Surgical Group Doctor: Date:
Office Visit Information (General Surgery) Amarillo Surgical Group Doctor: Date: Patient s Information Name: Last First Middle Social Security #: Date of Birth: Age Gender: [ Male / Female ] Marital Status:
More informationADULT History Form (To be filled out by the person seeking treatment)
1 ADULT History Form (To be filled out by the person seeking treatment) Client s Name Date: SS# - - DOB: / / Age: Person completing this form: Client Other: (give name) Who referred you to Namsate Counseling?
More informationMEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only
MEDICATION GUIDE MORPHINE Sulfate Oral Solution (mor-pheen) CII Rx only IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency
More informationA Prescription for Education. Hillary Dubois, Director of Prevention Services Amanda Sandoval, Asst. Director of Prevention Services
A Prescription for Education Hillary Dubois, Director of Prevention Services Amanda Sandoval, Asst. Director of Prevention Services Addiction Release of abnormally large amounts of neurotransmitters, mainly
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationTuscarawas County Health Department. Vivitrol Treatment Consent
Tuscarawas County Health Department Vivitrol Treatment Consent I. Vivitrol Medication Guide: a. VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) b. Read this Medication Guide
More informationNorthSTAR. Section II Substance Abuse and Chemical Dependency LEVEL OF CARE CRITERIA
NorthSTAR Section II Substance Abuse and Chemical Dependency LEVEL OF CARE CRITERIA 1 TABLE OF CONTENTS Level of Care Page Inpatient Detoxification Services (Hospital and 24 Hour Residential) 3 Outpatient
More informationWhat is the most important information I should know about Morphine Sulfate Oral Solution?
Medication Guide MORPHINE SULFATE (mor-pheen) (CII) Oral Solution IMPORTANT: Keep Morphine Sulfate Oral Solution in a safe place away from children. Accidental use by a child is a medical emergency and
More informationIntake Form. Presenting Problems and Concerns. When did it start and how does it affect you:
Intake Form Name: Date: Presenting Problems and Concerns Describe the problem that brought you here today: When did it start and how does it affect you: Estimate the severity of the above problem: Mild
More informationThe National Methamphetamine Symposium
The National Methamphetamine Symposium Making Research Work in Practice 12 May 2015 Arts Centre, Melbourne Physical and psychological effects of methamphetamine use Amanda Baker PhD National Centre for
More information